Krupin T, Singer P R, Perlmutter J, Kolker A E, Becker B
Arch Ophthalmol. 1981 May;99(5):840-1. doi: 10.1001/archopht.1981.03930010840010.
The initial topical administration of 1 drop of 0.25% timolol maleate in 25 nontreated ocular hypertensive patients resulted in a significant reduction of mean intraocular pressure one hour later, from a baseline of 28.1 +/- 5.3 (mean +/- SD) mm Hg to 18.5 +/- 4.5 mm Hg. Two patients (8%) failed to show at least a 10% decreases in IOP one hour after the initial administration. After three to four weeks of twice a day unilateral therapy with 0.25% timolol, mean IOP increased to 21.1 +/- 4.2 mm Hg. At this time seven patients (28%) failed to obtain a 10% decrease in IOP from topical timolol administration. Changing to 0.5% timolol for three to four weeks did not cause an additional significant lowering of IOP (20.4 +/- 3.5 mm Hg). At this time five patients (20%) had less than a 10% reduction in IOP. The one-hour response failed to predict future IOP nonresponsiveness.
对25名未经治疗的高眼压患者进行初始局部给药,滴入1滴0.25%的马来酸噻吗洛尔,一小时后平均眼压显著降低,从基线的28.1±5.3(均值±标准差)毫米汞柱降至18.5±4.5毫米汞柱。两名患者(8%)在初始给药一小时后眼压至少未降低10%。在用0.25%的马来酸噻吗洛尔每天两次进行单侧治疗三到四周后,平均眼压升至21.1±4.2毫米汞柱。此时,七名患者(28%)经局部使用马来酸噻吗洛尔后眼压未降低10%。改用0.5%的马来酸噻吗洛尔治疗三到四周后,眼压并未进一步显著降低(20.4±3.5毫米汞柱)。此时,五名患者(20%)眼压降低不到10%。一小时的反应无法预测未来眼压无反应情况。